Novel Insights into the Physiological and Pathological Role of Leptin and Leptin Receptor

A special issue of Receptors (ISSN 2813-2564).

Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 131

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, 87036 Arcavacata di Rende, CS, Italy
Interests: breast cancer; glioblastoma; seminoma; obesity; leptin; aromatase
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, CS, Italy
Interests: breast cancer; tumor microenvironment; adipokines; nuclear receptors; ESR1 mutations; endocrine-resistance; exosomes
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, research efforts have been expanded to clarify the role of leptin/leptin receptors in human physiology and in the pathophysiology of several disorders. However, more studies are needed to fully elucidate leptin/leptin receptor signaling pathways. The adipocyte-derived factor leptin and its receptor (ObR) are widely expressed in a large spectrum of tissues, wherein they play a pivotal role in energy homeostasis, metabolism, and in neuroendocrine and immune functions. Further, it has been demonstrated that the leptin/leptin receptor signaling pathway is linked to the proliferation, migration, and invasion of cancer cells. Indeed, targeting the leptin/leptin receptor has generated a great amount of interest in the design and development of several modulators that could offer a valuable therapeutic strategy in many diseases.

In this Special Issue, we welcome original research articles, as well as review articles, in order to provide new knowledge about the physiological and pathological significance of leptin/leptin receptors.

You may choose our Joint Special Issue in Biomolecules.

Dr. Salvatore Panza
Dr. Luca Gelsomino
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Receptors is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • leptin
  • leptin receptor
  • metabolic disorders
  • obesity
  • cancer

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop